- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
极度弱势行情中，投资者可暂时观望。
- 中期趋势：
回落整理中且下跌有加速趋势。
- 长期趋势：
已有191家主力机构披露2025-12-31报告期持股数据，持仓量总计5.16亿股，占流通A股27.38%
- 波段诊断：
-
技术面诊股
诊断结果：3.9技术面打败了17%的股票
技术面评分前10的股票
近期的平均成本为4.93元。多头行情中，目前处于回落整理阶段且下跌有加速趋势。
平均成本
近期的平均成本为4.93元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"4.93","date":1777276501,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑输行业平均水平。
[{"date":"2026.04.28","stock":"-0.40","trade":"-0.61","ind":"-1.10"},{"date":"2026.04.27","stock":"-4.99","trade":"0.54","ind":"0.37"},{"date":"2026.04.24","stock":"-3.70","trade":"-0.33","ind":"-0.69"},{"date":"2026.04.23","stock":"3.05","trade":"-1.30","ind":"-0.88"},{"date":"2026.04.22","stock":"-0.19","trade":"0.43","ind":"1.30"},{"date":"2026.04.21","stock":"1.74","trade":"-0.98","ind":"0.10"},{"date":"2026.04.20","stock":"0.58","trade":"-0.37","ind":"0.55"},{"date":"2026.04.17","stock":"-2.28","trade":"-1.46","ind":"0.60"},{"date":"2026.04.16","stock":"0.57","trade":"-0.14","ind":"2.05"},{"date":"2026.04.15","stock":"1.75","trade":"2.24","ind":"-0.97"},{"date":"2026.04.14","stock":"0.19","trade":"0.68","ind":"1.61"},{"date":"2026.04.13","stock":"-3.39","trade":"-0.85","ind":"0.69"},{"date":"2026.04.10","stock":"0.00","trade":"0.52","ind":"2.24"},{"date":"2026.04.09","stock":"-1.12","trade":"-2.18","ind":"-0.33"},{"date":"2026.04.08","stock":"2.29","trade":"1.06","ind":"4.79"},{"date":"2026.04.07","stock":"1.55","trade":"0.46","ind":"0.36"},{"date":"2026.04.03","stock":"-2.82","trade":"-2.72","ind":"-0.99"},{"date":"2026.04.02","stock":"-1.12","trade":"1.12","ind":"-1.60"},{"date":"2026.04.01","stock":"2.87","trade":"4.62","ind":"1.70"},{"date":"2026.03.31","stock":"-2.97","trade":"-0.68","ind":"-1.81"},{"date":"2026.03.30","stock":"3.26","trade":"0.96","ind":"-0.25"}]
华邦健康,深证成指,化学制药指数
压力支撑
该股压力位为4.92元，支撑位为4.86元。
[{"text":"\u538b\u529b\u4f4d","value":"4.92","date":1777305600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"4.86","date":1777305600,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌有加速趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.4资金面打败了10%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：04月28日 17:02
| 机构今日流向(万元) | -1939.59 | 机构5日流向(万元) | -5361.58 |
| 机构10日流向(万元) | -14536.22 | 机构20日流向(万元) | -22701.30 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加866.05万股，其中基金净减仓3家，主力净增仓57家，请投资者中长期谨慎为宜。
截止2025-12-31，共191家主力机构（基金187家，一般法人4家），持仓量总计51567.11万股，占流通A股27.38%
其中，基金持仓与2025-06-30相比：
增仓：32家 ，增持 587.57万股
减仓：35家 ，减持 379.19万股
新出现在主力名单中：118家 ，持有3616.41万股
从主力名单中消失：61家 ，原持有3921.83万股
其中，基金持仓与2025-06-30相比：
增仓：32家 ，增持 587.57万股
减仓：35家 ，减持 379.19万股
新出现在主力名单中：118家 ，持有3616.41万股
从主力名单中消失：61家 ，原持有3921.83万股
消息面诊股
诊断结果：6.2消息面打败了56%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 华邦健康：4月27日获融资买入4303.13万元
2026-04-28 - 华邦健康：4月24日获融资买入2919.68万元
2026-04-27 - 股东追踪|鹏华优质治理混合(LOF)A新进华邦健康
2026-04-24 - 华邦健康一季度营收逾28亿元 经营性现金流大幅改善
2026-04-24 - 财报速递：华邦健康2026年一季度净利润1.55亿
2026-04-27 - 华邦健康：第一季度净利润1.55亿元，同比下降16
2026-04-24 - 华邦健康：4月23日获融资买入2703.84万元
2026-04-24 - 慎扩张、降融资！重庆低调医药大佬熬过难关，华邦健康
2026-04-24 - 华邦健康：4月22日获融资买入1097.50万元
2026-04-23 - 华邦健康（截止2026年3月31日）股东人数为71
2026-04-22
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-23 |
| 利好 | 分红转增 | 10派2.5元(含税) | 2026-04-23 |
| 一般消息 | 高管变动 | 由于个人原因 | 2026-04-17 |
| 利好 | 业绩预告 | 预计扭亏 | 2026-01-21 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-14 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-13 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-06 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-12-31 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-10-28 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-27 |
| 利好 | 分红转增 | 10派2元(含税) | 2025-08-20 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2025-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-07 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-04 |
| 一般消息 | 高管变动 | 公司取消监事会 | 2025-05-14 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 5条 | 0条 | 5条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.3行业面打败了70%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2026.04.28","price":"-1.10","value":"-0.61"},{"date":"2026.04.27","price":"0.37","value":"0.54"},{"date":"2026.04.24","price":"-0.69","value":"-0.33"},{"date":"2026.04.23","price":"-0.88","value":"-1.30"},{"date":"2026.04.22","price":"1.30","value":"0.43"},{"date":"2026.04.21","price":"0.10","value":"-0.98"},{"date":"2026.04.20","price":"0.55","value":"-0.37"},{"date":"2026.04.17","price":"0.60","value":"-1.46"},{"date":"2026.04.16","price":"2.05","value":"-0.14"},{"date":"2026.04.15","price":"-0.97","value":"2.24"},{"date":"2026.04.14","price":"1.61","value":"0.68"},{"date":"2026.04.13","price":"0.69","value":"-0.85"},{"date":"2026.04.10","price":"2.24","value":"0.52"},{"date":"2026.04.09","price":"-0.33","value":"-2.18"},{"date":"2026.04.08","price":"4.79","value":"1.06"},{"date":"2026.04.07","price":"0.36","value":"0.46"},{"date":"2026.04.03","price":"-0.99","value":"-2.72"},{"date":"2026.04.02","price":"-1.60","value":"1.12"},{"date":"2026.04.01","price":"1.70","value":"4.62"},{"date":"2026.03.31","price":"-1.81","value":"-0.68"},{"date":"2026.03.30","price":"-0.25","value":"0.96"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 美诺华 | 39.49% | 14.45% | 6.2分 |
| 2 | 纳微科技 | 33.07% | 5.94% | 6.1分 |
| 3 | 津药药业 | 29.83% | -2.06% | 5.4分 |
| 4 | 莱美药业 | 23.38% | -2.48% | 5.0分 |
| 5 | 多瑞医药 | 22.88% | -1.02% | 5.6分 |
| 6 | 博瑞医药 | 21.28% | 5.21% | 5.2分 |
| 8 | 一品红 | 17.48% | 9.01% | 5.7分 |
| 10 | 汇宇制药 | 13.94% | 2.37% | 5.2分 |
| 12 | 益方生物 | 13.68% | 3.98% | 5.6分 |
| 14 | 昂利康 | 12.98% | -9.64% | 5.8分 |
| 16 | - | 12.56% | -0.74% | 分 |
| 18 | 罗欣药业 | 11.99% | 9.98% | 6.2分 |
| 20 | 悦康药业 | 10.98% | 1.76% | 5.0分 |
| 22 | 司太立 | 9.65% | 10.16% | 5.0分 |
| 24 | 前沿生物 | 8.31% | 14.42% | 5.5分 |
| 26 | 兴齐眼药 | 6.77% | 6.61% | 5.6分 |
| 28 | 华纳药厂 | 6.38% | 2.18% | 5.6分 |
| 30 | 仟源医药 | 5.66% | 0.49% | 6.4分 |
| 32 | - | 5.24% | -4.51% | 分 |
| 34 | 威尔药业 | 4.72% | 2.39% | 6.8分 |
| 36 | 键凯科技 | 4.63% | -8.94% | 5.1分 |
| 38 | - | 4.54% | -1.80% | 分 |
| 40 | - | 4.10% | -2.94% | 分 |
| 42 | 科源制药 | 3.68% | -0.15% | 6.2分 |
| 44 | 誉衡药业 | 3.44% | -3.22% | 5.3分 |
| 46 | - | 3.00% | -1.04% | 分 |
| 48 | 奥翔药业 | 2.83% | 3.14% | 4.5分 |
| 50 | - | 2.17% | 0.23% | 分 |
| 52 | 民生健康 | 1.83% | 1.26% | 5.6分 |
| 54 | 海创药业 | 1.59% | -7.52% | 4.3分 |
| 56 | 德展健康 | 1.42% | 8.48% | 5.0分 |
| 58 | 尔康制药 | 1.24% | 0.25% | 5.2分 |
| 60 | ST天圣 | 0.78% | 3.60% | 5.6分 |
| 62 | - | 0.62% | -1.44% | 分 |
| 64 | 天新药业 | 0.11% | 0.57% | 5.5分 |
| 66 | 金陵药业 | 0.00% | -6.41% | 5.1分 |
| 68 | 福安药业 | -0.24% | -0.72% | 4.9分 |
| 70 | 恩华药业 | -0.71% | 5.95% | 5.9分 |
| 72 | ST人福 | -1.12% | -0.53% | 5.3分 |
| 74 | - | -1.13% | -5.50% | 分 |
| 76 | 诚意药业 | -1.34% | -0.51% | 5.6分 |
| 78 | 百利天恒 | -1.52% | -7.77% | 4.5分 |
| 80 | 恒瑞医药 | -1.65% | -1.63% | 5.8分 |
| 82 | 同和药业 | -1.74% | 0.00% | 5.1分 |
| 84 | 华海药业 | -2.35% | -2.77% | 5.0分 |
| 86 | 丰原药业 | -2.59% | -1.39% | 5.5分 |
| 88 | 新天地 | -2.70% | -1.62% | 4.8分 |
| 90 | 华北制药 | -2.96% | -2.60% | 4.6分 |
| 92 | 仙琚制药 | -3.09% | -1.68% | 5.4分 |
| 94 | 神奇制药 | -3.29% | 0.68% | 5.8分 |
| 96 | 汉商集团 | -3.58% | -0.12% | 4.9分 |
| 98 | 健友股份 | -3.97% | 0.21% | 5.4分 |
| 100 | 华润双鹤 | -4.13% | -1.38% | 5.2分 |
| 102 | 艾力斯 | -4.24% | -3.81% | 5.2分 |
| 104 | 溢多利 | -4.36% | 2.91% | 5.3分 |
| 106 | 灵康药业 | -4.60% | -0.46% | 5.3分 |
| 108 | 亚虹医药 | -4.86% | -3.34% | 4.6分 |
| 110 | 宣泰医药 | -5.03% | -2.26% | 4.7分 |
| 112 | 新华制药 | -5.11% | -1.18% | 4.7分 |
| 114 | 华东医药 | -5.12% | -0.94% | 5.1分 |
| 116 | 海森药业 | -5.39% | -2.61% | 4.1分 |
| 118 | 国邦医药 | -6.03% | -0.91% | 5.5分 |
| 120 | 科伦药业 | -6.11% | -2.80% | 4.6分 |
| 122 | 新诺威 | -6.51% | -5.72% | 4.5分 |
| 124 | 拓新药业 | -6.93% | -3.75% | 3.6分 |
| 126 | 永安药业 | -7.01% | -3.34% | 4.7分 |
| 128 | 东诚药业 | -7.11% | -2.96% | 4.6分 |
| 130 | 花园生物 | -7.26% | -3.80% | 3.5分 |
| 132 | 亚太药业 | -7.80% | -7.93% | 3.8分 |
| 134 | 九典制药 | -8.09% | -6.62% | 4.0分 |
| 136 | 华邦健康 | -8.53% | -6.27% | 4.6分 |
| 138 | 中关村 | -9.13% | -6.77% | 5.4分 |
| 140 | 上海谊众 | -9.45% | 0.38% | 4.9分 |
| 142 | 辰欣药业 | -10.15% | -3.81% | 4.2分 |
| 144 | 北陆药业 | -10.37% | -6.72% | 4.7分 |
| 146 | 海辰药业 | -11.03% | -5.19% | 4.6分 |
| 148 | 浙江医药 | -11.99% | -0.68% | 4.8分 |
| 150 | 润都股份 | -12.94% | 12.11% | 6.0分 |
| 152 | 亿帆医药 | -13.18% | -5.54% | 4.4分 |
| 154 | 必贝特 | -14.05% | -13.24% | 4.5分 |
| 156 | 能特科技 | -15.96% | -1.06% | 4.8分 |
| 158 | *ST赛隆 | -20.48% | -22.56% | 4.5分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 51/220 ， 62/220。
[{"date":"2026-03-31","value":"1.50","vol":"0.30"},{"date":"2025-12-31","value":"7.29","vol":"0.34"},{"date":"2025-09-30","value":"6.43","vol":"1.53"},{"date":"2025-06-30","value":"4.07","vol":"1.23"},{"date":"2025-03-31","value":"1.95","vol":"-0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.50 | 7.29 | 6.43 | 4.07 | 1.95 |
| 行业(%) | 0.30 | 0.34 | 1.53 | 1.23 | -0.13 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"35.87","vol":"51.31"},{"date":"2025-12-31","value":"36.92","vol":"51.90"},{"date":"2025-09-30","value":"37.01","vol":"49.60"},{"date":"2025-06-30","value":"36.28","vol":"49.57"},{"date":"2025-03-31","value":"37.12","vol":"49.05"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
35.87 | 36.92 | 37.01 | 36.28 | 37.12 |
| 行业(%) | 51.31 | 51.90 | 49.60 | 49.57 | 49.05 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 49/220 ， 55/220。
[{"date":"2026-03-31","value":"-0.08","vol":"26.70"},{"date":"2025-12-31","value":"-1.31","vol":"48.57"},{"date":"2025-09-30","value":"1.98","vol":"141.64"},{"date":"2025-06-30","value":"0.39","vol":"78.57"},{"date":"2025-03-31","value":"-3.24","vol":"0.03"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-0.08 | -1.31 | 1.98 | 0.39 | -3.24 |
| 行业(%) | 26.70 | 48.57 | 141.64 | 78.57 | 0.03 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"-16.01","vol":"16.72"},{"date":"2025-12-31","value":"338.53","vol":"-17.72"},{"date":"2025-09-30","value":"35.37","vol":"-2.93"},{"date":"2025-06-30","value":"23.90","vol":"58.23"},{"date":"2025-03-31","value":"18.50","vol":"-10.52"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-16.01 | 338.53 | 35.37 | 23.90 | 18.50 |
| 行业(%) | 16.72 | -17.72 | -2.93 | 58.23 | -10.52 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 50/220 ， 21/220。
[{"date":"2026-03-31","value":"0.10","vol":"0.11"},{"date":"2025-12-31","value":"0.39","vol":"0.42"},{"date":"2025-09-30","value":"0.31","vol":"0.31"},{"date":"2025-06-30","value":"0.20","vol":"0.21"},{"date":"2025-03-31","value":"0.10","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.10 | 0.39 | 0.31 | 0.20 | 0.10 |
| 行业(次) | 0.11 | 0.42 | 0.31 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.92","vol":"0.69"},{"date":"2025-12-31","value":"3.40","vol":"2.66"},{"date":"2025-09-30","value":"2.68","vol":"1.93"},{"date":"2025-06-30","value":"1.71","vol":"1.29"},{"date":"2025-03-31","value":"0.78","vol":"0.65"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.92 | 3.40 | 2.68 | 1.71 | 0.78 |
| 行业(次) | 0.69 | 2.66 | 1.93 | 1.29 | 0.65 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"7.61","vol":"0.10"},{"date":"2025-12-31","value":"39.74","vol":"16.91"},{"date":"2025-09-30","value":"18.96","vol":"4.27"},{"date":"2025-06-30","value":"15.96","vol":"2.95"},{"date":"2025-03-31","value":"1.34","vol":"-26.34"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 7.61 | 39.74 | 18.96 | 15.96 | 1.34 |
| 行业 | 0.10 | 16.91 | 4.27 | 2.95 | -26.34 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.56","vol":"1.69"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.59","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.56 | - | 0.59 | - |
| 行业 | 0.00 | 1.69 | 0.00 | 1.71 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 30/220 ， 3/220。
[{"date":"2026-03-31","value":"1.40","vol":"3.94"},{"date":"2025-12-31","value":"1.26","vol":"3.61"},{"date":"2025-09-30","value":"1.34","vol":"3.48"},{"date":"2025-06-30","value":"1.23","vol":"3.66"},{"date":"2025-03-31","value":"1.14","vol":"3.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
1.40 | 1.26 | 1.34 | 1.23 | 1.14 |
| 行业 | 3.94 | 3.61 | 3.48 | 3.66 | 3.57 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.94","vol":"3.26"},{"date":"2025-12-31","value":"0.78","vol":"2.97"},{"date":"2025-09-30","value":"0.91","vol":"2.73"},{"date":"2025-06-30","value":"0.86","vol":"2.88"},{"date":"2025-03-31","value":"0.74","vol":"2.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.94 | 0.78 | 0.91 | 0.86 | 0.74 |
| 行业 | 3.26 | 2.97 | 2.73 | 2.88 | 2.80 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 15/220 ， 14/220。
[{"date":"2026-03-31","value":"41.89","vol":"31.08"},{"date":"2025-12-31","value":"41.51","vol":"32.47"},{"date":"2025-09-30","value":"44.95","vol":"34.05"},{"date":"2025-06-30","value":"46.17","vol":"34.11"},{"date":"2025-03-31","value":"47.30","vol":"34.08"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
41.89 | 41.51 | 44.95 | 46.17 | 47.30 |
| 行业(%) | 31.08 | 32.47 | 34.05 | 34.11 | 34.08 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.20","vol":"14.39"},{"date":"2025-12-31","value":"1.18","vol":"1.64"},{"date":"2025-09-30","value":"1.36","vol":"1.19"},{"date":"2025-06-30","value":"1.40","vol":"0.87"},{"date":"2025-03-31","value":"1.48","vol":"1.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.20 | 1.18 | 1.36 | 1.40 | 1.48 |
| 行业(%) | 14.39 | 1.64 | 1.19 | 0.87 | 1.44 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"4.33","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"3.02","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-2.99","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"7.13","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]